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Introduction to the JID Symposium Supplement
53rd Annual Montagna Symposium on the Biology of Skin
‘‘Keratinocyte and Melanocyte Cancers of the Skin: Interacting Pathways’’
Salishan Lodge, Gleneden Beach, Oregon, Oct. 15–19, 2004
This year, the 53rd Annual Montagna Symposium on the
Biology of Skin moved back to Oregon and to Salishan
Lodge. Held October 15–19, 2004, it was as a joint meeting
with the 6th International Skin Carcinogenesis Conference.
The joint meeting brought a record turnout, being fully sub-
scribed with approximately 140 participants. We also had
both long and short talks, while still following the tradition
established in 1950 by Dr. William Montagna, who estab-
lished a forum where basic cutaneous biologists and clin-
ically trained scientists met to discuss a single major topic
in cutaneous biology. The topic for the 53rd Annual
Montagna Symposium was ‘‘Keratinocyte and Melanocyte
Cancers of the Skin: Interacting Pathways.’’ As in past
symposia, the flow of presentations was designed to lead
the discussion from the basic aspects of skin biology to
potential clinical applications.
We began the Symposium with two keynote talks on
Friday night. Brian Drucker shared the steps from target
idea to molecular-based cancer remission in human me-
senchymal tumors and Meenhard Herlyn described net-
works of communication between melanocytes and
melanoma cells. Over the next three and a half days, we
had seven sessions with very lively discussions, a breakout
session where we all discussed where cancer research
should go in the future and possibilities for translating the
research to the bedside, and a final wrap-up session in
which G. Tim Bowden highlighted keratinocyte cancer
paths and the questions for the future and Meenhard Her-
lyn highlighted melanoma paths, challenges and directions
for the future.
Multistage Carcinogenesis: In the sessions concerning
multistage carcinogenesis, it was clear that the models of
choice were humanized mice. To highlight a few of the talks,
John DiGiovanni used expression of STAT3 in the supraba-
sal cells to mimic the human melanomas. Jim Rheinwald
showed that we need to suppress p16 in order to prevent
squamous cell carcinoma (SCC). Glenn Merlino tied these
talks together by showing that p16 was also a melanoma
suppressor. Petra Boukamp discussed the role of telom-
erase in carcinogenesis and showed that the telomere
localization appeared to be disarranged in tumors.
Basal Cell/Metastatic Paths: In the first session about
basal cell metabolic paths, several signaling pathways were
highlighted, including sonic hedgehog by Andrzej Dlugosz
and NFkB by Rune To¨ftgard. In the second session, PKC
pathways and immunosuppression were discussed as risk
factors for skin cancer, and Susan Fischer highlighted pros-
taglandins and their role in skin carcinogenesis.
Intra/Intercellular Signaling: After an invigorating hike
through forest to a magnificent Pacific coast ridge view, we
discussed intracellular and intercellular signaling. A few
highlights were Brian Nickoloff sharing the new information
that notch-2 is overexpressed in melanoma and benign
nevi; Stuart Yuspa showing that CLIC4, a chloride channel,
is downregulated in carcinoma cells; and Xiao-Jing Wang
demonstrating that her knockout model of SMAD3 resisted
2-stage chemical carcinogenesis.
Growth/Differentiation/Apoptosis/p53: Several talks in
this session highlighted the role of p63, a p53 isoform.
Dennis Roop and Frank McKeon debated the role that p63
plays in the maintenance of epidermal progenitor cells and
epithelial stratification.
Prevention and Therapeutics: In the clinical sessions
concerning prevention, several potential preventive agents
were discussed, including a novel telomere-based DNA
strategy described by Barbara Gilchrest.
Etiology/Interactive Paths: In the final session several in-
teractive paths between keratinocyte and melanocyte car-
cinogenesis were discussed, including importance of cell
size regulation by Brandt Schneider, p53 family pathways
and common gene expression changes between mouse
models and human skin cancer by Molly Kulesz-Martin, and
ultraviolet-A by Tim Bowden.
Overall, the general consensus was that the pace of
basic research in skin cancers mechanisms has accelerat-
ed, but we need to translate these advances into new mo-
lecular therapies. A wish list was developed for what is
needed in the future for cancer research: better imaging;
optimum balance and connections between individual re-
searchers and consortia, genomic and proteomic databas-
es; new directions for repair of DNA damage in skin
after sun exposure; better animal models in which to con-
duct cancer research strategies; and more meetings like this
one, that bring together groups who study various cancers.
As in the previous year, the Eugene M. Farber family
generously provided support for outstanding young inves-
tigators to travel to the 53rd Montagna Symposium to
present their research.
The 2004 Eugene M. Farber Young Investigator
Research Award Winners:
Neil F. Box, Baylor College of Medicine, Houston, Texas
The Sooty Foot Ataxia mouse: A new model for p53 path-
way melanoma?
Christophe Cataisson, National Cancer Institute, Bet-
hesda, Maryland
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Targeting overexpression of PKCa to the epidermis of
transgenic mice enhances tumor formation independent of
the inflammatory response
Mark S. Eller, Boston University School of Medicine,
Boston, Massachusetts
A Role for WRN in Generating Telomere-Based DNA Dam-
age Responses
Laura A. Hansen, Creighton University School of Med-
icine, Omaha, Nebraska
Chemoprevention of ultraviolet light-induced skin tumori-
genesis by inhibition of the epidermal growth factor recep-
tor
Yinling Hu, University of Texas MD Anderson Cancer
Center, Smithville, Texas
IKKa functions as a potential suppressor in skin carcino-
genesis
Eve Kandyba, University of Glasgow, UK
Gap junctional intercellular communication and Cx43 ex-
pression in human melanocytes and melanocytic lesions
Guanqun (Allen) Li, Oregon Health & Science University,
Portland, Oregon
Smad3 knockout mice exhibit a resistance to skin chemical
carcinogenesis
Maria Teresa Mancuso, ENEA CR-Casaccia, Rome, Italy
Susceptibility to BCC induction by radiation in Ptch1neo6-
7/þmice is hair growth cycle- dependent
Kathleen L. Tober, The Ohio State University, Columbus,
Ohio
The role of the EP prostanoid receptor, EP1 in acute UVB-
mediated inflammation and tumor development
Sun Yang, University of California Irvine Medical Center,
Orange, California
Alterations in Activating Protein-1 (AP-1) Composition Cor-
related with Phenotypic Differentiation Changes of Human
Melanoma Induced by Resveratrol
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